| Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors KM El-Gamal, AM El-Morsy, AM Saad, IH Eissa, M Alswah Journal of Molecular Structure 1166, 15-33, 2018 | 85 | 2018 |
| Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and … M Alswah, AH Bayoumi, K Elgamal, A Elmorsy, S Ihmaid, HEA Ahmed Molecules 23 (1), 48, 2017 | 82 | 2017 |
| Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors MS Alesawy, AA Al‐Karmalawy, EB Elkaeed, M Alswah, A Belal, ... Archiv der Pharmazie - Chemistry in Life Sciences 354 (3), 2000237, 2020 | 64 | 2020 |
| Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors IH Eissa, AM Metwaly, A Belal, ABM Mehany, RR Ayyad, K El‐Adl, ... Archiv der Pharmazie - Chemistry in Life Sciences 352 (11), 1900123, 2019 | 62 | 2019 |
| The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors MH El-Shershaby, KM El-Gamal, AH Bayoumi, K El-Adl, M Alswah, ... New Journal of Chemistry 45 (31), 13986-14004, 2021 | 48 | 2021 |
| From phenylthiazoles to phenylpyrazoles: broadening the antibacterial spectrum toward carbapenem-resistant bacteria A Hammad, NS Abutaleb, MM Elsebaei, AB Norvil, M Alswah, AO Ali, ... Journal of medicinal chemistry 62 (17), 7998-8010, 2019 | 45 | 2019 |
| Synthesis and biological evaluation of some [1, 2, 4] triazolo [4, 3-a] quinoxaline derivatives as novel anticonvulsant agents M Alswah, A Ghiaty, A El-Morsy, K El-Gamal International Scholarly Research Notices 2013, 2013 | 41 | 2013 |
| 5‐(4‐Methoxybenzylidene) thiazolidine‐2, 4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations K El‐Adl, H Sakr, M Nasser, M Alswah, FMA Shoman Archiv der Pharmazie 353 (9), 2000079, 2020 | 38 | 2020 |
| Design, synthesis, and molecular docking studies of new [1,2,4] triazolo[4,3‑a]quinoxaline derivatives as potential A2B receptor antagonists HG Ezzat, AH Bayoumi, FF Sherbiny, AME Morsy, A Ghiaty, M Alswah, ... Molecular Diversity 25, 291-306, 2020 | 33 | 2020 |
| Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1, 2, 4] triazolo [4, 3-a] quinoxaline analogues targeting DHFR and E. coli DNA gyrase B AM Omar, M Alswah, HEA Ahmed, AH Bayoumi, KM El-Gamal, A El-Morsy, ... Bioorganic Chemistry 96, 103656, 2020 | 28 | 2020 |
| Design, molecular docking, synthesis, anticancer and anti-hyperglycemic assessments of thiazolidine-2, 4-diones bearing sulfonylthiourea moieties as potent VEGFR-2 inhibitors … MA Abdelgawad, K El-Adl, SSA El-Hddad, MM Elhady, NM Saleh, ... Pharmaceuticals 15 (2), 226, 2022 | 26 | 2022 |
| A New Theobromine-Based EGFRWT and EGFRT790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro … EB Elkaeed, RG Yousef, H Elkady, AA Alsfouk, DZ Husein, IM Ibrahim, ... Processes 10 (11), 2290, 2022 | 11 | 2022 |
| Design, synthesis, anticancer, and docking of some S‐and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors K El‐Adl, AAH Abdel‐Rahman, AM Omar, M Alswah, NM Saleh Archiv der Pharmazie 355 (2), 2100237, 2022 | 7 | 2022 |
| Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by … AKB Aljohani, WAZ El Zaloa, M Alswah, MA Seleem, MM Elsebaei, ... International Journal of Molecular Sciences 24 (19), 15026, 2023 | 1 | 2023 |
| Synthesis and biological evaluation of novel pyrazolo [3, 4-d] pyrimidine derivatives of expected anticancer activity M Alswah Al-Azhar Journal of Pharmaceutical Sciences 64 (2), 80-92, 2021 | 1 | 2021 |
| SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL PYRAZOLO [3, 4-D] PYRIMIDINE DERIVATIVES OF EXPECTED ANTICANCER ACTIVITY WA Zaki, M Alswah, MM Elsebai, A Hassan | 1 | |
| N-and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity AA Awaji, WAZ El Zaloa, MA Seleem, M Alswah, MM Elsebaei, ... Bioorganic Chemistry, 107228, 2024 | | 2024 |
| Design, Synthesis, In Vitro, and In Silico Studies of New N5-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors WA Zaki, SM El-Sayed, M Alswah, A El-Morsy, AH Bayoumi, AS Mayhoub, ... Pharmaceuticals 16 (11), 1593, 2023 | | 2023 |
| Synthesis and Antimicrobial Activity of Phenylpyrazole Derivatives. A Hammad, AH Bayoumi, M Alswah, AS Mayhoub Al-AZHAR JOURNAL OF PHARMACEUTICAL SCIENCES 60 (September), 51-58, 2019 | | 2019 |
| Research Article Synthesis and Biological Evaluation of Some [1, 2, 4] Triazolo [4, 3-a] quinoxaline Derivatives as Novel Anticonvulsant Agents M Alswah, A Ghiaty, A El-Morsy, K El-Gamal | | 2013 |
Ibrahim H. EissaProfessor, Faculty of pharmacy, Al-Azhar UniversityVerified email at azhar.edu.eg
